🟡 Medium ImpactCorporate
Sun Pharma, Coforge eye overseas acquisitions amid weak domestic growth
Sun Pharma, Coforge eye overseas acquisitions amid weak domestic growth — Indian firms are targeting foreign buys as home market growth slows. Sun Pharma and Coforge are actively exploring international deals to diversify revenue. These strategic moves aim to leverage global opportunities while domestic demand remains subdued.
📊 STOCKS: SUNPHARMA, COFORGE | 🏢 SECTOR: Corporate | #MEDIUMIMPACT #Acquisition
#Acquisition#SunPharma#Coforge
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →